Skip to main content

Table 2 Patient characters significantly associated with higher or lower use of topical mTOR inhibitors based on the multivariate logistic regression

From: Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database

Parameter

Odds ratio (95% CI)

 

11–17 years age group

1.67 (1.01–2.79)

0.0473

Anxiety

1.57 (1.05–2.32)

0.0240

Angiomyolipoma

1.51 (1.12–2.04)

0.0070

Renal cysts

1.33 (1.00–1.77)

0.0477

  1. Data included in the multivariate analysis was from 1238 patients (Patients using topical mTOR inhibitor, N = 309; Patients not using topical mTOR inhibitor, N = 926)
  2. CI confidence interval; mTOR mechanistic target of rapamycin
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172